Unveiling the Burden of Postpartum Depression: New Treatment Approaches to a Debilitating Condition
Tracking # 20-1315046
Free
Course overview
The goal of this activity is to improve pharmacist knowledge and competence about postpartum depression (PPD), including epidemiology, pathophysiology, and current and novel treatments for PPD. Pharmacists play a vital role on a multidisciplinary team in integrating new therapy options for PPD and developing appropriate management strategies to improve patients quality of life.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Pharmacy
Pharmacist
Disclosure statements
Dr. Demler has disclosed that she has no actual or potential conflicts of interest in relation to this program.
The clinical reviewer, Sarah Dehoney, PharmD, BCPS has no actual or potential conflicts of interest in relation to this program.
The medical writer, Thomas Cook, RPh, PhD has no actual or potential conflicts of interest in relation to this program.
Susanne Kwas, MSHF, BSN, RN, Robin Soboti, RPh, and Susan R. Grady, MSN, RN as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
All relevant financial relationships have been mitigated.